HEPSEEVAX Trademark

Trademark Overview

On Thursday, April 9, 2015, a trademark application was filed for HEPSEEVAX with the United States Patent and Trademark Office. The USPTO has given the HEPSEEVAX trademark a serial number of 79166773. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, September 29, 2023. This trademark is owned by The Macfarlane Burnet Institute for Medical Research and Public Health Limited. The HEPSEEVAX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and medicinal preparations and substances for infectious diseases, namely, HIV, malaria, hepatitis C and tuberculosis; vaccines against hepatitis C

Product research and development; medical research; pharmaceutical research; diagnostic research and development in the field of infectious diseases, namely, HIV, malaria, tuberculosis and hepatitis including hepatitis C; consulting in the fields of medical and pharmaceutical research; medical research and development; medical research and development relating to the treatment of HIV, malaria, tuberculosis and hepatitis including hepatitis C; product research and development in the field of birthing and nutrition; provision of information in relation to the foregoing
hepseevax

General Information

Serial Number79166773
Word MarkHEPSEEVAX
Filing DateThursday, April 9, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, September 29, 2023
Registration Number5158326
Registration DateTuesday, March 14, 2017
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 27, 2016

Trademark Statements

Description of MarkThe mark consists of the wording "HEPSEEVAX" with a hexagon incorporating triangles.
Goods and ServicesPharmaceutical and medicinal preparations and substances for infectious diseases, namely, HIV, malaria, hepatitis C and tuberculosis; vaccines against hepatitis C
Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe wording "HEPSEEVAX" has no meaning in a foreign language.
NOT AVAILABLE"HEPCVAX"
Goods and ServicesProduct research and development; medical research; pharmaceutical research; diagnostic research and development in the field of infectious diseases, namely, HIV, malaria, tuberculosis and hepatitis including hepatitis C; consulting in the fields of medical and pharmaceutical research; medical research and development; medical research and development relating to the treatment of HIV, malaria, tuberculosis and hepatitis including hepatitis C; product research and development in the field of birthing and nutrition; provision of information in relation to the foregoing

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 29, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 29, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameThe Macfarlane Burnet Institute for Medical Research and Public Health Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressMelbourne VIC 3004
AU
Party NameThe Macfarlane Burnet Institute for Medical Research and Public Health Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressMelbourne VIC 3004
AU
Party NameThe Macfarlane Burnet Institute for Medical Research and Public Health Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMelbourne VIC 3004
AU

Trademark Events

Event DateEvent Description
Friday, July 17, 2015ASSIGNED TO EXAMINER
Thursday, June 11, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, June 13, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 17, 2015APPLICATION FILING RECEIPT MAILED
Friday, July 24, 2015NON-FINAL ACTION WRITTEN
Saturday, July 25, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, July 28, 2015REFUSAL PROCESSED BY MPU
Tuesday, July 28, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, August 15, 2015REFUSAL PROCESSED BY IB
Tuesday, January 26, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 26, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 27, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, January 30, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 23, 2016WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, March 9, 2016PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, April 8, 2016NON-FINAL ACTION WRITTEN
Friday, April 8, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 8, 2016NON-FINAL ACTION E-MAILED
Thursday, October 6, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 6, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 7, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 3, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 31, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 3, 2016PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, November 3, 2016EXAMINERS AMENDMENT -WRITTEN
Thursday, November 3, 2016EXAMINERS AMENDMENT E-MAILED
Wednesday, December 7, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, November 3, 2016EXAMINER'S AMENDMENT ENTERED
Thursday, November 3, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 16, 2016NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, November 16, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, November 17, 2016ASSIGNED TO LIE
Friday, November 18, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 2, 2016NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, December 7, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 7, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, December 27, 2016PUBLISHED FOR OPPOSITION
Friday, September 29, 2023CANCELLED SECTION 71
Friday, December 23, 2016NOTIFICATION PROCESSED BY IB
Tuesday, December 27, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, June 14, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, June 21, 2017GENERIC MADRID TRANSACTION CREATED
Thursday, June 22, 2017GENERIC MADRID TRANSACTION SENT TO IB
Friday, September 22, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, March 14, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, June 14, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sunday, July 14, 2024TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, June 20, 2024GENERIC MADRID TRANSACTION SENT TO IB
Thursday, June 20, 2024GENERIC MADRID TRANSACTION CREATED

Related Keywords

hepseevax research hepatitis development medical malaria pharmaceutical tuberculosis infectious field including